REQUEST A DEMO
Total
USD $0.00
Search more companies

Institut Za Kukuruz Zemun Polje (Serbia)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Institut Za Kukuruz Zemun Polje Profile Updated: October 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Institut Za Kukuruz Zemun Polje is an enterprise based in Serbia. Its main office is in Belgrade. The enterprise operates in the Research and Development in Biotechnology (except Nanobiotechnology) industry. It was established on 1945. The total number of employees is currently 285 (2023). In 2023, the company reported a net sales revenue drop of 15.55%. Its’ total assets recorded a growth of 0.6%. In, 2023, the company’s net profit margin decreased by 4.93%.

Headquarters
SLOBODANA BAJICA 1 -
Belgrade; Belgrade; Postal Code: www.mrizp.co.rs

Contact Details: Purchase the Institut Za Kukuruz Zemun Polje report to view the information.

Website: http://CUBE_PROFILES_YU

Basic Information
Total Employees:
Purchase the Institut Za Kukuruz Zemun Polje report to view the information.
Outstanding Shares:
Purchase the Institut Za Kukuruz Zemun Polje report to view the information.
Registered Capital:
Purchase the Institut Za Kukuruz Zemun Polje report to view the information.
Incorporation Date:
1945
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Subsidiaries
Hibrid D.O.O. Beograd
7.08%
Company Performance
Financial values in the chart are available after Institut Za Kukuruz Zemun Polje report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
-15.55%
Total operating revenue
37.75%
Operating profit (EBIT)
-91%
EBITDA
-54.7%
Net Profit (Loss) for the Period
-71.01%
Total assets
0.6%
Total equity
-0.56%
Operating Profit Margin (ROS)
-6.43%
Net Profit Margin
-4.93%
Return on Equity (ROE)
-4.95%
Debt to Equity Ratio
-0.16%
Quick Ratio
-1.32%
Cash Ratio
-1.45%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?